Companies / India
If you would like to subscribe to Middle East & Africa Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Middle East & Africa Pharma & Healthcare Insight please click on the trial link below.
Ranbaxy Enters Yemen
May 2008 | Company News AlertSorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Middle East & Africa Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Middle East & Africa Pharma & Healthcare Insight please click on the trial link below.
Indian generics multinational Ranbaxy Laboratories has entered Yemen's pharmaceutical market through a tie up with Yemen's National Trading Company (Natco). The deal will see Natco market a number of Ranbaxy's drugs in Yemen. Ranbaxy is currently seeking approval for several drugs, thought to include anti-infective, gastro-intestinal and anti-allergy products, with Yemen's Supreme Board for Drugs & Medical